迈瑞医疗2月2日获融资买入1.48亿元，融资余额42.87亿元

Core Viewpoint - On February 2, Mindray Medical experienced a decline of 1.14% in stock price with a trading volume of 1.259 billion yuan, indicating a challenging market environment for the company [1]. Financing and Margin Trading - On February 2, Mindray Medical had a financing buy amount of 148 million yuan and a financing repayment of 165 million yuan, resulting in a net financing outflow of 16.78 million yuan [1]. - As of February 2, the total margin trading balance for Mindray Medical was 4.336 billion yuan, with a financing balance of 4.287 billion yuan, accounting for 1.89% of the circulating market value, which is above the 90th percentile level over the past year [1]. - In terms of securities lending, on February 2, Mindray Medical had 700 shares repaid and 4,800 shares sold short, with a selling amount of approximately 898,100 yuan, and a remaining short position of 259,100 shares valued at 48.48 million yuan, also above the 80th percentile level over the past year [1]. Company Overview - Mindray Medical, established on January 25, 1999, and listed on October 16, 2018, is located in Shenzhen, China, and specializes in the research, manufacturing, marketing, and service of medical devices [2]. - The company's revenue composition includes in vitro diagnostic products (38.37%), life information and support products (32.73%), medical imaging products (19.78%), electrophysiology and vascular intervention products (7.25%), and other products (1.56%) [2]. - As of September 30, the number of shareholders for Mindray Medical was 108,800, an increase of 18.86% from the previous period, while the average circulating shares per person decreased by 15.87% to 11,139 shares [2]. Financial Performance - For the period from January to September 2025, Mindray Medical reported a revenue of 25.834 billion yuan, a year-on-year decrease of 12.38%, and a net profit attributable to shareholders of 7.570 billion yuan, down 28.83% year-on-year [2]. Dividend Distribution - Since its A-share listing, Mindray Medical has distributed a total of 35.336 billion yuan in dividends, with 25.025 billion yuan distributed over the past three years [3]. Institutional Holdings - As of September 30, 2025, the top ten circulating shareholders of Mindray Medical included Hong Kong Central Clearing Limited as the third-largest shareholder with 117 million shares, a decrease of 14.736 million shares from the previous period [3]. - Other notable institutional shareholders include E Fund's ChiNext ETF and Huatai-PB's CSI 300 ETF, both of which have seen reductions in their holdings [3].